tiprankstipranks
pc:lanov

LaNova Medicines

Pudong District Shanghai, CN
https://www.lanovamedicines.com/en
LaNova Medicines is a Chinese biopharmaceutical company focused on developing innovative cancer therapies. The company is advancing its pipeline with lead candidates such as LM-299, an anti-PD-1/VEGF bispecific antibody for advanced solid tumors, and other promising treatments targeting specific cancer pathways.

Leadership & Board

Current Number of Employees15
Current LinkedIn Followers568

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$42M
Total Amount Raised$42M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$42M
Latest Funding Amount$42M
Latest Funding RoundSeries C
Latest Funding RoundSeries C
Post-Money Valuation
Post-Money Valuation

Employee Trend

LaNova Medicines had 15 employees as of April 6, 2026. The number of employees increased by 0 (0.00%) week-over-week.
15Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

LaNova Medicines had 568 followers as of April 6, 2026. The number of followers increased by 4 (0.71%) week-over-week.
568Latest Followers Count
4(0.71%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Aug 14, 2025
Series C
$42.00M

Investors

Investor Name
Funding Round

Related News and Analysis